FDA has concluded that the existing regulatory frameworks for foods and supplements are not appropriate for cannabidiol and a new regulatory pathway is needed for CBD to manage the risks.|The consumption of CBD raises various safety issues (like…
FDA has concluded that the existing regulatory frameworks for foods and supplements are not appropriate for cannabidiol and a new regulatory pathway is needed for CBD to manage the risks.|The consumption of CBD raises various safety issues (like…
The most widely used genome-editing tool, CRISPR/Cas9, is easy to use and affordable. Genome sequencing technology has developed rapidly in recent years but it is still difficult to detect large deletions and structural variations.